TE7 Diagnostic Ultrasound System

K143472 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · IYN · Jan 2, 2015 · Radiology

Device Facts

• Record ID: K143472
• Device Name: TE7 Diagnostic Ultrasound System
• Applicant: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Product Code: IYN · Radiology
• Decision Date: Jan 2, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.1550
• Device Class: Class 2
• Attributes: Pediatric, 3rd-Party Reviewed

Intended Use

TE7 Diagnostic Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in fetal, abdominal,Intra-operative(abdominal, thoracic, and vascular) ,Pediatric.small organ(breast, thyroid, testes), neonatal and adult cephalic,trans-esoph. (Cardiac), trans-rectal, trans-vaginal, musculo-skeletal(conventional, superficial), urology, Peripheral vessel, Adult and Pediatric cardiac exams.

Device Story

TE7 is a software-controlled diagnostic ultrasound system; utilizes an array of probes (linear and convex, 3.0-10.0 MHz) to acquire ultrasound data; processes signals to display B-Mode, M-Mode, PW-Mode, CW-Mode, Power/Dirpower Mode, THI, LVO, and combined modes; used by clinicians in clinical settings for anatomical imaging and fluid flow analysis; provides onscreen visualization of structures and flow; supports biopsy guidance, measurements, and reporting; aids clinical decision-making by providing diagnostic information; benefits patients through non-invasive diagnostic imaging.

Clinical Evidence

No clinical data. Substantial equivalence is supported by bench testing, including acoustic output measurements (UD 2, UD 3), biocompatibility (ISO 10993-1), and electrical/mechanical safety (IEC 60601 series).

Technological Characteristics

Software-controlled ultrasonic diagnostic system; frequency range 3.0-10.0 MHz; supports B, M, PW, CW, Power/Dirpower, THI, and LVO modes. Complies with IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, and ISO 10993. Connectivity includes reporting and image annotation. Sterilization/disinfection per manufacturer guidelines.

Indications for Use

Indicated for adults, pregnant women, pediatric patients, and neonates for diagnostic ultrasound imaging and fluid flow analysis in fetal, abdominal, intra-operative (abdominal, thoracic, vascular), pediatric, small organ (breast, thyroid, testes), neonatal/adult cephalic, trans-esophageal (cardiac), trans-rectal, trans-vaginal, musculoskeletal (conventional, superficial), urology, peripheral vessel, and adult/pediatric cardiac exams.

Regulatory Classification

Identification

An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

• Mindray M9 (K141010)
• Mindray M7 (K131690)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. In the center of the seal is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. % Mr. Mark Job Regulatory Technology Services, LLC 1394 25th Street NW BUFFALO MN 55313

January 2, 2015

Re: K143472

Trade/Device Name: TE7 Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: October 31, 2014 Received: December 5, 2014

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA mav publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D.'Hara for

Janine Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

### Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement on last page.

510(k) Number (if known)

### K143472

Device Name TE7

### Indications for Use (Describe)

TE7 Diagnostic Ultrasound System is applicable for adults, pregnant woments and neonates. It is intended for use in fetal, abdominal,Intra-operative(abdominal, thoracic, and vascular) , Pediatric,small organ(breast, thyroid, testes), neonatal and adult cephalic,trans-esoph. (Cardiac), trans-raginal, musculo-skeletal(conventional, superficial), urology,Peripheral vessel, Adult and Pediatric cardiac exams.

Type of Use (Select one or both, as applicable)

∑ Prescription Use (Part 21 CFR 801 Subpart D)

□ Over-The-Counter Use (21 CFR 801 Subpart C)

### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

### FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

{3}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

## Diagnostic Ultrasound Indications For Use Format

System: TE7 Diagnostic Ultrasound System

Transducer: N/A

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Use:

| Clinical Application | | Mode of Operation | | | | | | | | |
|-------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|-------------------|-------------------|-----|-----|------------------|----------------------------|---------------------------|--------------------|--|
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitu<br>de<br>Doppler | Combine<br>d<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| | Fetal | N | N | N | N | N | N | N | Note 1,2 | |
| | Abdominal | N | N | N | N | N | N | N | Note 1,2 | |
| | Intra-operative (Specify*) | N | N | N | N | N | N | N | Note 1,2 | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | N | N | N | N | N | N | N | Note 1,2 | |
| | Small Organ (Specify**) | N | N | N | N | N | N | N | Note 1,2 | |
| | Neonatal Cephalic | N | N | N | N | N | N | N | Note 1,2 | |
| Fetal<br>Imaging & | Adult Cephalic | N | N | N | N | N | N | N | Note 1,2 | |
| Other | Trans-rectal | N | N | N | N | N | N | N | Note 1,2 | |
| | Trans-vaginal | N | N | N | N | N | N | N | Note 1,2 | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | N | N | N | N | N | N | N | Note 1,2 | |
| | Musculo-skeletal<br>(Superficial) | N | N | N | N | N | N | N | Note 1,2 | |
| | Intravascular | | | | | | | | | |
| | Cardiac Adult | N | N | N | N | N | N | N | Note 1,2,3 | |
| | Cardiac Pediatric | N | N | N | N | N | N | N | Note 1,2 | |
| Cardiac | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | N | N | N | N | N | N | N | Note 1 | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral | Peripheral vessel | N | N | N | N | N | N | N | Note 1,2 | |
| vessel | Other (Specify***) | N | N | N | N | N | N | N | Note 1,2 | |
| | N=new indication; P=previously cleared by FDA; E=added under Appendix E | | | | | | | | | |
| | Additional comments: Combined modes--B+M、PW+B、Color + B、Power + B、PW +Color+B、Power | | | | | | | | | |
| | * Intraoperative includes abdominal, thoracic, and vascular etc. | | | | | | | | | |
| | ** Small organ-breast, thyroid, testes. | | | | | | | | | |
| | ***Other use includes Urology. | | | | | | | | | |
| | Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. | | | | | | | | | |
| | Note2: Biopsy Guidance | | | | | | | | | |
| | Note3: Contrast imaging (Contrast agent for LVO) | | | | | | | | | |
| | (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) | | | | | | | | | |
| | Concurrence of CDRH, Office of Device Evaluation(ODE) | | | | | | | | | |
| Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | | |
| Clinical Application | Mode of Operation | | | | | | | | | |
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitude<br>de<br>Doppler | Combined<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| | Fetal | | | | | | | | | |
| | Abdominal | P | P | P | | P | P | P | Note 1,2 | |
| | Intra-operative (Specify*) | | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | P | P | P | | P | P | P | Note 1,2 | |
| | Small Organ (Specify**) | | | | | | | | | |
| | Neonatal Cephalic | P | P | P | | P | P | P | Note 1,2 | |
| Fetal<br>Imaging & | Adult Cephalic | | | | | | | | | |
| Other | Trans-rectal | | | | | | | | | |
| | Trans-vaginal | | | | | | | | | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal | | | | | | | | | |
| | (Conventional) | | | | | | | | | |
| | Musculo-skeletal | | | | | | | | | |
| | (Superficial) | | | | | | | | | |
| | Intravascular | | | | | | | | | |
| | Cardiac Adult | | | | | | | | | |
| | Cardiac Pediatric | P | P | P | | P | P | P | Note 1,2 | |
| Cardiac | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | | | | | | | | | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral | Peripheral vessel | P | P | P | | P | P | P | Note 1,2 | |
| vessel | Other (Specify***) | | | | | | | | | |
| N=new indication; P=previously cleared by FDA(k141010); E=added under Appendix E | | | | | | | | | | |
| Additional comments: Combined modes--B+M、PW+B、Color + B、Power + B、PW+Color+B、Power | | | | | | | | | | |
| *Intraoperative includes abdominal, thoracic, and vascular etc. | | | | | | | | | | |
| **Small organ-breast, thyroid, testes. | | | | | | | | | | |
| ***Other use includes Urology. | | | | | | | | | | |
| Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. | | | | | | | | | | |
| Note2: Biopsy Guidance | | | | | | | | | | |
| Note3: Contrast imaging (Contrast agent for LVO) | | | | | | | | | | |
| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) | | | | | | | | | | |
| Concurrence of CDRH, Office of Device Evaluation(ODE) | | | | | | | | | | |
| Prescription USE (Per 21 CFR 801.109) | | | | | | | | | | |
| Clinical Application | | Mode of Operation | | | | | | | | |
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitu<br>de<br>Doppler | Combine<br>d<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| | Fetal | P | P | P | | P | P | P | Note 1,2 | |
| | Abdominal | P | P | P | | P | P | P | Note 1,2 | |
| | Intra-operative (Specify*) | | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | P | P | P | | P | P | P | Note 1,2 | |
| | Small Organ (Specify**) | | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | | |
| Fetal | Adult Cephalic | | | | | | | | | |
| Imaging &<br>Other | Trans-rectal | | | | | | | | | |
| | Trans-vaginal | | | | | | | | | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal | | | | | | | | | |
| | (Conventional) | | | | | | | | | |
| | Musculo-skeletal | | | | | | | | | |
| | (Superficial) | | | | | | | | | |
| | Intravascular | | | | | | | | | |
| | Cardiac Adult | | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | | |
| Cardiac | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | | | | | | | | | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral | Peripheral vessel | P | P | P | | P | P | P | Note 1,2 | |
| vessel | Other (Specify***) | | | | | | | | | |
| | N=new indication; P=previously cleared by FDA(k131690); E=added under Appendix E | | | | | | | | | |
| | Additional comments: Combined modes--B+M、PW+B、Color + B、Power + B、PW+Color+B、Power | | | | | | | | | |
| *Intraoperative includes abdominal, thoracic, and vascular etc. | | | | | | | | | | |
| ** Small organ-breast, thyroid, testes. | | | | | | | | | | |
| ***Other use includes Urology. | | | | | | | | | | |
| Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. | | | | | | | | | | |
| Note2: Biopsy Guidance | | | | | | | | | | |
| Note3: Contrast imaging (Contrast agent for LVO) | | | | | | | | | | |
| | (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) | | | | | | | | | |
| | Concurrence of CDRH, Office of Device Evaluation(ODE) | | | | | | | | | |
| | Prescription USE (Per 21 CFR 801.109) | | | | | | | | | |
| Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | | |
| Clinical Application | | Mode of Operation | | | | | | | | |
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitu<br>de<br>Doppler | Combine<br>d<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| Fetal<br>Imaging &<br>Other | Fetal | | | | | | | | | |
| | Abdominal | | | | | | | | | |
| | Intra-operative (Specify*) | | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | | | | | | | | | |
| | Small Organ (Specify**) | | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | | |
| | Adult Cephalic | | | | | | | | | |
| | Trans-rectal | | | | | | | | | |
| | Trans-vaginal | | | | | | | | | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | | | | | | | | | |
| | Musculo-skeletal<br>(Superficial) | | | | | | | | | |
| | Intravascular | | | | | | | | | |
| Cardiac | Cardiac Adult | | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | | |
| | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | P | P | P | P | P | P | P | Note 1 | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral<br>vessel | Peripheral vessel | | | | | | | | | |
| | Other (Specify***) | | | | | | | | | |
| N=new indication; P=previously cleared by FDA(k131690); E=added under Appendix E | | | | | | | | | | |
| Additional comments: Combined modes--B+M、PW+B、Color + B、Power + B、PW +Color+B、Power | | | | | | | | | | |
| *Intraoperative includes abdominal, thoracic, and vascular etc. | | | | | | | | | | |
| **Small organ-breast, thyroid, testes. | | | | | | | | | | |
| ***Other use includes Urology. | | | | | | | | | | |
| Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. | | | | | | | | | | |
| Note2: Biopsy Guidance | | | | | | | | | | |
| Note3: Contrast imaging (Contrast agent for LVO) | | | | | | | | | | |
| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) | | | | | | | | | | |
| Concurrence of CDRH, Office of Device Evaluation(ODE) | | | | | | | | | | |
| Prescription USE (Per 21 CFR 801.109) | | | | | | | | | | |
| Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | | |
| | Clinical Application | | Mode of Operation | | | | | | | |
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitu<br>de<br>Doppler | Combined<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| | Fetal | | | | | | | | | |
| | Abdominal | P | P | P | | P | P | P | Note 1,2 | |
| | Intra-operative (Specify*) | | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | P | P | P | | P | P | P | Note 1,2 | |
| | Small Organ (Specify**) | P | P | P | | P | P | P | Note 1,2 | |
| | Neonatal Cephalic | | | | | | | | | |
| Fetal<br>Imaging & | Adult Cephalic | | | | | | | | | |
| Other | Trans-rectal | | | | | | | | | |
| | Trans-vaginal | | | | | | | | | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal<br>(Conventional) | P | P | P | | P | P | P | Note 1,2 | |
| | Musculo-skeletal<br>(Superficial) | P | P | P | | P | P | P | Note 1,2 | |
| | Intravascular | | | | | | | | | |
| | Cardiac Adult | | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | | |
| Cardiac | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | | | | | | | | | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral | Peripheral vessel | P | P | P | | P | P | P | Note 1,2 | |
| vessel | Other (Specify***) | | | | | | | | | |
| | N=new indication; P=previously cleared by FDA(k131690); E=added under Appendix E | | | | | | | | | |
| | Additional comments: Combined modes--B+M、PW+B、Color + B、Power + B、PW+Color+ B、Power | | | | | | | | | |
| | *Intraoperative includes abdominal, thoracic, and vascular etc. | | | | | | | | | |
| | ** Small organ-breast, thyroid, testes. | | | | | | | | | |
| | ***Other use includes Urology. | | | | | | | | | |
| | Note 1: Tissue Harmonic Imaging. The feature does not use contrast agents. | | | | | | | | | |
| | Note2: Biopsy Guidance | | | | | | | | | |
| | Note3: Contrast imaging (Contrast agent for LVO) | | | | | | | | | |
| | (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED) | | | | | | | | | |
| | Concurrence of CDRH, Office of Device Evaluation(ODE) | | | | | | | | | |
| | Prescription USE (Per 21 CFR 801.109) | | | | | | | | | |

Prescription USE (Per 21 CFR 801.109)

{5}------------------------------------------------

System: TE7 Diagnostic Ultrasound System

Transducer: C11-3s

{6}------------------------------------------------

System: TE7 Diagnostic Ultrasound System

Transducer: C5-2s Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

{7}------------------------------------------------

### System: TE7 Diagnostic Ultrasound System

Transducer: P7-3Ts

{8}------------------------------------------------

| System: | | TE7 Diagnostic Ultrasound System |
|---------|--|----------------------------------|
|---------|--|----------------------------------|

Transducer: L12-4s

{9}------------------------------------------------

| Clinical Application | | Mode of Operation | | | | | | | | |
|------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|---|-----|-----|-------------------|----------------------------|---------------------------|--------------------|--|
| General<br>(Track 1<br>Only) | Specific (Track 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Amplitu<br>de<br>Doppler | Combine<br>d<br>(specify) | Other<br>(specify) | |
| Ophthalmic | Ophthalmic | | | | | | | | | |
| | Fetal | | | | | | | | | |
| | Abdominal | P | P | P | | P | P | P | Note 1,2 | |
| | Intra-operative (Specify*) | | | | | | | | | |
| | Intra-operative (Neuro) | | | | | | | | | |
| | Laparoscopic | | | | | | | | | |
| | Pediatric | P | P | P | | P | P | P | Note 1,2 | |
| | Small Organ (Specify**) | P | P | P | | P | P | P | Note 1,2 | |
| | Neonatal Cephalic | | | | | | | | | |
| Fetal<br>Imaging & | Adult Cephalic | | | | | | | | | |
| Other | Trans-rectal | | | | | | | | | |
| | Trans-vaginal | | | | | | | | | |
| | Trans-urethral | | | | | | | | | |
| | Trans-esoph. (non-Card.) | | | | | | | | | |
| | Musculo-skeletal | P | P | P | | P | P | P | Note 1,2 | |
| | (Conventional) | | | | | | | | | |
| | Musculo-skeletal<br>(Superficial) | P | P | P | | P | P | P | Note 1,2 | |
| | Intravascular | | | | | | | | | |
| | Cardiac Adult | | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | | |
| Cardiac | Intravascular (Cardiac) | | | | | | | | | |
| | Trans-esoph. (Cardiac) | | | | | | | | | |
| | Intra-cardiac | | | | | | | | | |
| Peripheral | Peripheral vessel | P | P | P…